PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Punjab University, Chandigarh India.\', \'Assistant Professor of Pharmaceutics, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India.\', \'Assistant Professor of Pharmacology, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/14728222.2021.1918103
?:hasPublicationType
?:journal
  • Expert opinion on therapeutic targets
is ?:pmid of
?:pmid
?:pmid
  • 33857397
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.597
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33857397>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33857397>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all